SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-21-000228
Filing Date
2021-01-12
Accepted
2021-01-12 16:30:08
Documents
14
Period of Report
2021-01-12

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_011221.htm 6-K 6245
2 PRESS RELEASE exh_991.htm EX-99.1 7414
3 EXHIBIT 99.2 exh_992.htm EX-99.2 18320
4 exh992_01.jpg GRAPHIC 192160
5 exh992_02.jpg GRAPHIC 355808
6 exh992_03.jpg GRAPHIC 149027
7 exh992_04.jpg GRAPHIC 201649
8 exh992_05.jpg GRAPHIC 273401
9 exh992_06.jpg GRAPHIC 252890
10 exh992_07.jpg GRAPHIC 180501
11 exh992_08.jpg GRAPHIC 159452
12 exh992_09.jpg GRAPHIC 182713
13 exh992_10.jpg GRAPHIC 93658
14 exh992_11.jpg GRAPHIC 205774
  Complete submission text file 0001171843-21-000228.txt   3126863
Mailing Address OSTERGADE 24A, 1 COPENHAGEN G7 1100
Business Address OSTERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242
Forward Pharma A/S (Filer) CIK: 0001604924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36686 | Film No.: 21523808
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences